| By Marketwire . | Article Rating: |
|
| January 21, 2013 06:15 AM EST | Reads: |
415 |
SUGAR LAND, TX -- (Marketwire) -- 01/21/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With the economy still gyrating between growth and despair, it is gratifying to offer some positive news from the Pharmaceutical-Biotech Industry. As revealed by a recent analysis of active reported projects that are scheduled to begin construction in 2013, according to Industrial Info's Pharmaceutical Tracker - Online Database, a projected $16.9 billion is allocated among 681 active capital and maintenance projects.
Other companies featured: Baxter International Corporation (NYSE:BAX), Nanoviricides Incorporated (OTC:NNVC)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=232752&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact:
Joe Govreau
713-783-5147
Published January 21, 2013 Reads 415
Copyright © 2013 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Marketwire .
Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Market Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

